Prostate Cancer - Results from #920

REVIEW UroToday

The current role of high-intensity focused ultrasound for the management of radiation-recurrent prostate cancer, "Beyond the Abstract," by Petros Sountoulides, MD, PhD, FEBU and Alexandros Theodosiou, MD March 26, 2013

Routine transition zone biopsy during active surveillance for prostate cancer rarely provides unique evidence of disease progression, "Beyond the Abstract," by Sven Wenske, MD March 25, 2013

Repeat transrectal prostate biopsies in diagnosing prostate cancer, "Beyond the Abstract," by I. V. Bakardzhiev March 20, 2013

Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? "Beyond the Abstract," by Hashim Uddin Ahmed, MRCS, et al March 20, 2013

Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer, "Beyond the Abstract," by Amit Algotar, MD, PhD March 18, 2013

Chronic asymptomatic inflammation of the prostate type IV and carcinoma of the prostate: Is there a correlation? "Beyond the Abstract," by Paul F. Engelhardt, FEBU March 14, 2013

An accurate prostate cancer prognosticator using a seven-gene signature plus Gleason score and taking cell type heterogeneity into account, "Beyond the Abstract," by Dan Mercola, MD, PhD March 13, 2013

"Beyond the Abstract," The REDUCE metagram: A comprehensive prediction tool for determining the utility of dutasteride chemoprevention in men at risk for prostate cancer, by Brandon K. Isariyawongse, MD and Michael W. Kattan, MBA, PhD March 12, 2013

Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions, "Beyond the Abstract," by Li Jia, PhD March 12, 2013

Uncertainty and perception of danger among patients undergoing treatment for prostate cancer, "Beyond the Abstract," by Sarah P. Psutka MD March 9, 2013

Transperineal magnetic resonance image-targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer, "Beyond the Abstract," by Veeru Kasivisvanathan, MBBS, BSc, MRCS March 4, 2013

Prostate treatment with helical TomoTherapy in patients with bilateral hip prostheses-two case studies, "Beyond the Abstract," by Justin Kling, BS, DC, CMD and Kamal M. Patel, MD March 1, 2013

Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer, "Beyond the Abstract," by Thomas Kislinger, PhD, et al February 26, 2013

Is further evaluation needed for incidental focal uptake in the prostate in 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography images? "Beyond the Abstract," by Seung Il Jung, MD, PhD February 11, 2013

TGFβ1 induces apoptosis in invasive prostate cancer and bladder cancer cells via Akt-independent, p38 MAPK and JNK/SAPK-mediated activation of caspases, "Beyond the Abstract," by Ahmad Al-Azayzih, PharmD and Payaningal R. Somanath, PhD February 8, 2013

Hypofractionated proton boost combined with external beam radiotherapy for treatment of localized prostate cancer, "Beyond the Abstract," by Silvia Johansson, MD, PhD February 7, 2013

High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer, "Beyond the Abstract," by Ernesto R. Cordeiro Feijoo, MD February 5, 2013

Trends in prostatic adenocarcinoma tumor volume by visual estimation in prostatectomy specimens, "Beyond the Abstract," by Ian F. Green, BS and Debra L. Zynger, MD, MS February 5, 2013

An examination of variations in the uptake of prostate cancer screening within and between the countries of the EU-27, "Beyond the Abstract," by Richéal Burns, BA MEconSc, et al. February 4, 2013

In vivo biomarker expression patterns are preserved in 3D cultures of prostate cancer, "Beyond the Abstract," by Louisa C.E. Windus February 4, 2013

Page 47 of 57